Read article at the link below:
https://www.businesswire.com/news/home/20241211633894/en/Cyrus-Biotechnology-Announces-Potent-in-vivo-Redosability-of-an-Engineered-IdeS-Protease-for-IgG-driven-Autoimmune-Disease-Demonstrating-No-Anti-drug-Antibodies
